Lung Transplant Specimen Repository and Data Registry Protocol
1 other identifier
observational
64
1 country
1
Brief Summary
All patients enrolled in the registry will be recipients of single and double lung transplantation (bilateral sequential, heart-lung, or living related donor grafts). During the routine management of lung recipients frequent surveillance of the lung allograft is necessary. This routinely involves: measurement of pulmonary functions, chest radiography, collection of peripheral blood to assess other organ function and monitor therapeutic drug levels, and bronchoscopic evaluation allowing for collection of lung lavage fluid and lung tissue biopsy. This surveillance normally follows a set schedule during the first one to two years following the transplant procedure. Surveillance is routinely performed at weeks 2, 8, 12, 24, 36, and 52 during the first year following the transplant procedure. Additional surveillance may be performed at any time when clinically indicated for the optimal management of the recipient. Information and specimens collected from each of these encounters will be entered in the data registry and specimen repository.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 31, 2008
CompletedFirst Posted
Study publicly available on registry
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedNovember 20, 2013
November 1, 2013
8 years
December 31, 2008
November 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
data registry and lung tissue repository
ongoing
Eligibility Criteria
lung transplant recipients
You may qualify if:
- recipients of single and double lung transplantation (bilateral sequential, heart-lung, or living related donor grafts).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karen Woodlead
Study Sites (1)
The Ohio State University
Columbus, Ohio, 43210, United States
Biospecimen
BAL specimen blood lung biopsy specimens
Study Officials
- PRINCIPAL INVESTIGATOR
David Nunley, MD
Ohio State University
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Karen Wood M.D.
Study Record Dates
First Submitted
December 31, 2008
First Posted
January 1, 2009
Study Start
November 1, 2005
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
November 20, 2013
Record last verified: 2013-11